Carlsmed Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Carlsmed Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- CARL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001794546
Board of directors
-
Jonathan D. Root · DirectorSince 2025
-
Kevin C. Oboyle · DirectorSince 2025
-
Kevin Sidow · DirectorSince 2025
-
Michael Cordonnier · Director · CEO, PresidentSince 2025
-
Niall Casey · Director · Chief IP OfficerSince 2025
-
Philip M. Young · DirectorSince 2025
-
Robert Mittendorff II · DirectorSince 2025
Chief executives
Michael Cordonnier
· CEO, President
Since July 2025
Board connections
2 of this board's directors also sit on 4 other boards.
- via Jonathan D. Root
- via Jonathan D. Root
- via Kevin C. Oboyle
- via Kevin C. Oboyle
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,629,493
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | Kevin C. Oboyle Director | Grant or award | +13,698 | — | — |
| Jun 3, 2026 | Kevin Sidow Director | Grant or award | +13,698 | — | — |
| Jun 3, 2026 | Jonathan D. Root Director | Grant or award | +13,698 | — | — |
| Jun 3, 2026 | Philip M. Young Director | Grant or award | +13,698 | — | — |
| Mar 3, 2026 | Michael Cordonnier Director, Officer (CEO, President) | Option exercise | +160,567 | $0.34 | $54,593 |
| Mar 3, 2026 | Michael Cordonnier Director, Officer (CEO, President) | Option exercise | +33,264 | $4.35 | $144,698 |
| Mar 2, 2026 | Michael Cordonnier Director, Officer (CEO, President) | Option exercise | +197,855 | $0.34 | $67,271 |
| Mar 2, 2026 | Michael Cordonnier Director, Officer (CEO, President) | Open-market sale | −197,855 | $13.29 | $2,629,493 |
| Jan 28, 2026 | Durall William Scott Officer (Chief Commercial Officer) | Grant or award | +44,977 | — | — |
| Jan 28, 2026 | Niall Casey Director, Officer (Chief IP Officer) | Grant or award | +44,977 | — | — |
| Jan 28, 2026 | Michael Cordonnier Director, Officer (CEO, President) | Grant or award | +117,316 | — | — |
| Jan 28, 2026 | Greenstein Leonard M. Officer (CFO, Treasurer) | Grant or award | +44,977 | — | — |
| Jul 24, 2025 | B Capital Healthcare I, L.P. 10% owner | Derivative conversion | +3,680,506 | — | — |
| Jul 24, 2025 | Presidio Management Group XII, L.L.C. 10% owner | Derivative conversion | +2,948,794 | — | — |
| Jul 24, 2025 | Michael Cordonnier Director, Officer (CEO, President) | Option exercise | +3,612 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.